B E Mahon1, E D Mintz, K D Greene, J G Wells, R V Tauxe. 1. Foodborne and Diarrheal Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333 USA.
Abstract
OBJECTIVE: To describe US cholera surveillance data from 1992 to 1994 and the domestic impact of the epidemics of Vibrio cholerae O1 in Latin America and V cholerae O139 in Asia. DESIGN, SETTING, AND PARTICIPANTS: Retrospective review of surveillance data from all cases of cholera reported to the Centers for Disease Control and Prevention (CDC) from January 1, 1992, through December 31, 1994, in the United States and its territories. MAIN OUTCOME MEASURES: Clinical, epidemiologic, and laboratory surveillance data. RESULTS: From 1992 through 1994, 160 cases of cholera were reported to CDC by 20 states and 1 territory. This is a marked increase: only 136 cases were reported from 1965 through 1991. Outbreaks affecting 75 passengers on an airplane from Latin America and 5 passengers on a cruise ship in Southeast Asia accounted for 50 percent of cases. Vibrio cholerae O139 caused 6 cases (4 percent). The proportion of V cholerae O1 isolates resistant to at least 1 antimicrobial agent rose from 3 percent in 1992 to 93 percent in 1994. Of 158 patients whose location of exposure was known, 151 (96 percent) acquired infection abroad (125 in Latin America, 26 in Asia). Of 105 persons whose reason for travel was known, 31 (30 percent) were US residents who had returned to their country of origin to visit family or friends, and 65 (62 percent) were non-US residents visiting the United States from cholera-affected countries. The cholera rate among persons arriving in the United States from cholera-affected regions was 0.27 case per 100000 air travelers, not substantially increased from earlier estimates. CONCLUSIONS: Cholera has increased in the United States since 1991, reflecting global changes in cholera epidemiology, and is now primarily travel associated and antimicrobial resistant. Most travelers were not traditional tourists; reaching them with prevention measures may be difficult. The risk of cholera to the individual traveler remains extremely low.
OBJECTIVE: To describe US cholera surveillance data from 1992 to 1994 and the domestic impact of the epidemics of Vibrio cholerae O1 in Latin America and V cholerae O139 in Asia. DESIGN, SETTING, AND PARTICIPANTS: Retrospective review of surveillance data from all cases of cholera reported to the Centers for Disease Control and Prevention (CDC) from January 1, 1992, through December 31, 1994, in the United States and its territories. MAIN OUTCOME MEASURES: Clinical, epidemiologic, and laboratory surveillance data. RESULTS: From 1992 through 1994, 160 cases of cholera were reported to CDC by 20 states and 1 territory. This is a marked increase: only 136 cases were reported from 1965 through 1991. Outbreaks affecting 75 passengers on an airplane from Latin America and 5 passengers on a cruise ship in Southeast Asia accounted for 50 percent of cases. Vibrio cholerae O139 caused 6 cases (4 percent). The proportion of V cholerae O1 isolates resistant to at least 1 antimicrobial agent rose from 3 percent in 1992 to 93 percent in 1994. Of 158 patients whose location of exposure was known, 151 (96 percent) acquired infection abroad (125 in Latin America, 26 in Asia). Of 105 persons whose reason for travel was known, 31 (30 percent) were US residents who had returned to their country of origin to visit family or friends, and 65 (62 percent) were non-US residents visiting the United States from cholera-affected countries. The cholera rate among persons arriving in the United States from cholera-affected regions was 0.27 case per 100000 air travelers, not substantially increased from earlier estimates. CONCLUSIONS: Cholera has increased in the United States since 1991, reflecting global changes in cholera epidemiology, and is now primarily travel associated and antimicrobial resistant. Most travelers were not traditional tourists; reaching them with prevention measures may be difficult. The risk of cholera to the individual traveler remains extremely low.
Authors: Valérie R Louis; Estelle Russek-Cohen; Nipa Choopun; Irma N G Rivera; Brian Gangle; Sunny C Jiang; Andrea Rubin; Jonathan A Patz; Anwar Huq; Rita R Colwell Journal: Appl Environ Microbiol Date: 2003-05 Impact factor: 4.792
Authors: Wilbur H Chen; Mitchell B Cohen; Beth D Kirkpatrick; Rebecca C Brady; David Galloway; Marc Gurwith; Robert H Hall; Robert A Kessler; Michael Lock; Douglas Haney; Caroline E Lyon; Marcela F Pasetti; Jakub K Simon; Flora Szabo; Sharon Tennant; Myron M Levine Journal: Clin Infect Dis Date: 2016-03-21 Impact factor: 9.079
Authors: Anna E Newton; Katherine E Heiman; Ann Schmitz; Tom Török; Andria Apostolou; Heather Hanson; Prabhu Gounder; Susan Bohm; Katie Kurkjian; Michele Parsons; Deborah Talkington; Steven Stroika; Lawrence C Madoff; Franny Elson; David Sweat; Venessa Cantu; Okey Akwari; Barbara E Mahon; Eric D Mintz Journal: Emerg Infect Dis Date: 2011-11 Impact factor: 6.883
Authors: A Loharikar; A E Newton; S Stroika; M Freeman; K D Greene; M B Parsons; C Bopp; D Talkington; E D Mintz; B E Mahon Journal: Epidemiol Infect Date: 2014-05-27 Impact factor: 4.434
Authors: P S Mead; L Slutsker; V Dietz; L F McCaig; J S Bresee; C Shapiro; P M Griffin; R V Tauxe Journal: Emerg Infect Dis Date: 1999 Sep-Oct Impact factor: 6.883